Evi1 also represses TGF-β signaling via Smad3; the mutation in Evi1 affects the TGFβ/Smad3 pathway, which plays a critical role in increasing TGF-β levels and inducing colonic cancer in the absence of IL-10 (39). This evidence concerns the gene TGFB1 and malignant colon neoplasm.